Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07241533
NA

Asiaticoside for Treating Overweight/Obesity

Sponsor: Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

Centella asiatica is a traditional herbal medicine widely used in China and Southeast Asia for treating various conditions. Preclinical studies have shown that madecassic acid glycosides, including asiaticoside and madecassoside, can significantly reduce body weight gain, adipose tissue mass, and serum triglyceride levels in high-fat diet-induced obese mice. These compounds also improve hepatic steatosis and insulin resistance. This exploratory, interventional study aims to evaluate the clinical efficacy of orally administered asiaticoside tablets in adults with overweight or obesity.

Official title: A Clinical Efficacy Study of Asiaticoside for Treating Overweight/Obesity

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-12-01

Completion Date

2026-11

Last Updated

2025-12-24

Healthy Volunteers

No

Interventions

DRUG

Asiaticoside tablets

Asiaticoside tablets 60mg tid for 12 weeks

Locations (1)

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China